EMA - biosimilar medicines approved in the European Union (EU) are interchangeable

28th September 2022

EMA

EMA and the Heads of Medicines Agencies (HMA) have issued a joint statement confirming that biosimilar medicines approved in the European Union (EU) are interchangeable with their reference medicine or with an equivalent biosimilar.

Read More

Back to News Archive